Ignite Creation Date:
2024-05-06 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03130881
Status:
UNKNOWN
Last Update Posted:
2020-03-04
First Post:
2017-04-19
Brief Title:
Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK NSCLC
Sponsor:
Beijing Pearl Biotechnology Limited Liability Company
Organization:
Beijing Pearl Biotechnology Limited Liability Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer |
Keywords: